BioRestorative Therapies, Inc.
BRTX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001505497
No open-market purchases or sales by BioRestorative Therapies, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.00M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in BioRestorative Therapies, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- 0 vs. Q3 2023
- Shares held
- 312.4K
- −50.5K (−13.9%) vs. Q3 2023
- Total value
- $540.9K
- −$107.8K (−16.6%) vs. Q3 2023
- New holders
- 3
- 2 more added
- Sold out
- 3
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.00M |
| Q1 2026 | 14 | $184.2K |
| Q4 2025 | 16 | $383.4K |
| Q3 2025 | 17 | $550.3K |
| Q2 2025 | 18 | $413.9K |
| Q1 2025 | 17 | $501.8K |
| Q4 2024 | 17 | $405.6K |
| Q3 2024 | 17 | $471.9K |
| Q2 2024 | 15 | $520.0K |
| Q1 2024 | 15 | $531.0K |
| Q4 2023 | 15 | $540.9K |
| Q3 2023 | 15 | $648.7K |
| Q2 2023 | 14 | $1.42M |
| Q1 2023 | 17 | $1.02M |
| Q4 2022 | 18 | $900.4K |
| Q3 2022 | 19 | $1.16M |
| Q2 2022 | 16 | $975.1K |
| Q1 2022 | 17 | $1.80M |
| Q4 2021 | 13 | $1.72M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 2 | $12.0K |
| Q1 2021 | 1 | $30.0K |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding BioRestorative Therapies, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 120,633 | $209.9K | 0.00% | −17,185−12.5% | Reduced |
| Geode Capital Management, LLC | 43,278 | $74.0K | 0.00% | 00.0% | Unchanged |
| Wealth Alliance | 40,000 | $69.6K | 0.01% | 00.0% | Unchanged |
| Mariner, LLC | 26,831 | $46.7K | 0.00% | +163+0.6% | Added |
| StoneX Group Inc. | 23,880 | $41.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 20,459 | $35.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 19,700 | $34.3K | 0.00% | −4,900−19.9% | Reduced |
| HRT Financial LP | 12,485 | $21.0K | 0.00% | +12,485 | New |
| Advisor Group Holdings, Inc. | 2,194 | $3.82K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,951 | $3.40K | 0.00% | −7,394−79.1% | Reduced |
| Tower Research Capital LLC (TRC) | 844 | $1.47K | 0.00% | +844 | New |
| UBS Group AG | 94 | $164 | 0.00% | +93+9,300.0% | Added |
| Bank of America Corp | 54 | $94 | 0.00% | +54 | New |
| Parallel Advisors, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Lynwood Capital Management Inc. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −14,665−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |